Clinical trial
Intravenous Magnesium Sulfate Versus Paracetamol for the Treatment of Acute Non-Traumatic Headache in the Emergency Department: A Randomized Double-Blind Controlled Trial
NCT07779486 is registered in ClinicalTrials.gov with University of Monastir as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravenous Magnesium Sulfate Versus Paracetamol for the Treatment of Acute Non-Traumatic Headache in the Emergency Department: A Randomized Double-Blind Controlled Trial
- Lead sponsor
- University of Monastir
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 1, 2026
- Completion date
- December 31, 2030
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute headache, cluster headache, migraine, tension-type headache